BECAUSE ACCURACY MATTERS

Magnolia Medical Technologies is transforming medical care for providers and patients

SteriPath Gen2 Blood Culture Collection System
Steripath Logo

Eliminate blood culture contamination.

Steripath is the only technology clinically proven to virtually eliminate the preventable error of blood culture contamination and false-positive results for sepsis.

THE EVIDENCE

Clinically Proven, Guaranteed Results.

UNMC Clinical Trials

Used by reputable hospitals around the country and proven in countless clinical trials– Steripath has been clinically proven to sustain a blood culture rate of 0.2% and a reduction in false positives by 92%.

MUSC Health Achieves Unprecedented Results

The Medical University of South Carolina achieved a nearly four-fold decrease in contaminated blood cultures in their Emergency Department, sustained over 20 months. They discuss their experience with Steripath and the impact that improved sepsis diagnostic accuracy has on patient safety.

events:

American Society for Microbiology 2018

www.asm.org
June 7-11, 2018 | Atlanta, GA | Booth #1932
events:

APIC Annual Conference 2018

www.apic.com
June 13-15, 2018 | Minneapolis, MN | Booth #1339

Through our focus on specimen integrity and testing accuracy, we aim to:

ELIMINATE
MILLION
patient misdiagnoses and ensuing mistreatments
PREVENT
MILLION
patients from exposure to unnecessary antibiotics
SAVE
lives at minimum
CREATE OVER
BILLION
in direct cost savings for our hospital customers

The Scientist

behind Steripath

Transforming Medical Care for Providers and Patients

We are focused on improving critical processes and technologies to deliver unprecedented efficiency, effectiveness, and optimal patient outcomes.  With over 42 patents in our portfolio, we’ll keep innovating until we change the status quo.